AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaron-M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Walron Healthcare Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaron-M 50mg/500mg Tablet

Diabetol Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps mitigate severe diabetic complications like vision impairment and kidney disease, potentially lowering stroke and heart attack risks. Diabetol Duo 50mg/500mg may be used independently or with other antidiabetic treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health, glucose levels, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Maintaining the prescribed diet and exercise regimen is crucial for effective diabetes control; lifestyle significantly impacts management. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management. This medication isn't universally suitable. Prior to use, disclose any history of liver, kidney, or heart conditions, pancreatic issues, or significant alcohol consumption to your doctor. Pregnant or lactating individuals should seek medical counsel before commencing treatment. Interactions with other medications are possible; inform your physician of all medications to ensure safety. Alcohol consumption should be limited due to its potential to reduce blood glucose. Your physician will monitor kidney function and blood sugar levels throughout the treatment period.

Uses of Sitaron-M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitaron-M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Sitaron-M 50mg/500mg tablets should be administered with a meal.

Common Side effects of Sitaron-M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaron-M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 50mg/500mg Sitaron-M tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Sitaron-M 50mg/500mg Tablet works:

Sitaron-M 50mg/500mg tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaron-M 50mg/500mg Tablet with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaron-M 50mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Sitaron-M 50mg/500mg tablets are likely incompatible. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaron-M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitaron-M 50mg/500mg Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitaron-M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician. Medical consultation is recommended.

What if you forget to take Sitaron-M 50mg/500mg Tablet :

Should you forget to take your Sitaron-M 50mg/500mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Sitaron-M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitaron-M 50mg/500mg Tablet

Sitaron-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitaron-M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaron-M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Sitaron-M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaron-M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaron-M 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitaron-M and seek immediate medical attention.
Sitaron-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaron-M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaron-M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaron-M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitaron-M 50mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitaron-M and seek immediate medical attention.
Prolonged use of Sitaron-M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, potentially impacting mental function. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaron-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaron-M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaron-M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaron-M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Sitaron-M 50mg/500mg tablets. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitaron-M immediately and seek medical attention.
Prolonged Sitaron-M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitaron-M 50mg/500mg Tabl...
148